BIOLIPOX AB Patent applications |
Patent application number | Title | Published |
20140065203 | ANTIHISTAMINE- AND CORTICOSTEROID-CONTAINING LIPOSOME COMPOSITION AND ITS USE FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING RHINITIS AND RELATED DISORDERS - There is provided homogeneous pharmaceutical compositions for the treatment of, for example, rhinitis, asthma and/or chronic obstructive pulmonary disease comprising a corticosteroid and an antihistamine, a polar lipid liposome and a pharmaceutical-acceptable aqueous carrier. | 03-06-2014 |
20130039969 | Method And Composition For Treating Rhinitis - There is provided pharmaceutical compositions for the treatment of rhinitis by, for example, nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutical acceptable aqueous carrier. The compositions are preferably homogeneous in their nature. | 02-14-2013 |
20120035217 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors - There is provided compounds of formula I, | 02-09-2012 |
20120029016 | Indoles Useful in the Treatment of Inflammation - There is provided compounds of formula I, wherein ring R | 02-02-2012 |
20120004244 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors - There is provided compounds of formula I, | 01-05-2012 |
20120004228 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors - There is provided compounds of formula I, | 01-05-2012 |
20110319431 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors - There is provided compounds of formula I, | 12-29-2011 |
20090143440 | Pyrazoles Useful in the Treatment of Inflammation - There is provided compounds of formula (I), wherein R | 06-04-2009 |
20090069384 | THIENOPYRROLES USEFUL IN THE TREATMENT OF INFLAMMATION - There is provided compounds of formula I: wherein the dotted lines, U5 V5 X | 03-12-2009 |
20080287522 | BENZYLATED PDE4 INHIBITORS - The present invention is directed to a method for reducing the emetogenic effects of PDE inhibitors, and more particularly is directed to compounds having PDE4 inhibition activity with little or no emetogenic side-effects, and chemical methods including benzylation for preparing such compounds. A benzyl group may be attached to either a carbon or nitrogen atom of a PDE4 inhibitor. Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, and then react the resulting nucleophilic PDE4 inhibitor with a benzylating agent, e.g., benzyl bromide or a derivative thereof. | 11-20-2008 |